Projects per year
A phase 2 study of venetoclax in combination with low-dose cytarabine in relapsing acute myeloid leukemia.
22/09/19 → 31/12/24
A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) versus Epoetin Alfa for the Treatment of Anemia due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naive Subjects who require Red Blood Cell Transfusions.
Tiong, I. S. & Kennedy, N.
15/07/19 → 31/12/24
Establishing a Monash Partners national reference centre for molecular monitoring of residual disease (MRD) in acute myeloid leukaemia
1/01/17 → 31/12/19